JW Therapeutics: JW Therapeutics Co. Ltd Reports Earnings Results for the Half Year Ended June 30, 2024

JW (Cayman) Therapeutics Co. Ltd reported earnings results for the half year ended June 30, 2024. For the half year, the company reported sales was CNY 86.82 million compared to CNY 87.74 million a year ago. Net loss was CNY 240.27 million compared to CNY 380.42 million a year ago. Basic loss per share from continuing operations was CNY 0.58 compared to CNY 0.93 a year ago. Diluted loss per share from continuing operations was CNY 0.58 compared to CNY 0.93 a year ago.